...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Exploration of Emodin to treat alpha-naphthylisothiocyanate-induced cholestatic hepatitis via anti-inflammatory pathway.
【24h】

Exploration of Emodin to treat alpha-naphthylisothiocyanate-induced cholestatic hepatitis via anti-inflammatory pathway.

机译:探索大黄素通过抗炎途径治疗α-萘基异硫氰酸酯诱导的胆汁淤积性肝炎。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Emodin, 1,3,8-trihydroxy-6-methyl-anthraquinone, is an anthraquinone derivative from the roots of Rheum officinale Baill that has been used to treat many diseases in digestive system for thousands of years. This study is to disclose the mechanism of Emodin to treat cholestatic hepatitis via anti-inflammatory pathway. Rats were divided into Emodin, ursodeoxycholic acid, Dexamethasone, model and blank control groups with treatment of respective agent after administration of alpha-naphthylisothiocyanate. At 24 h, 48 h and 72 h time points after administration, liver function, pathological changes of hepatic tissue, tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, myeloperoxidase (MPO), malondialdehyde (MDA), superoxide dismutase (SOD), cytokine-induced neutrophil chemoattractant (CINC)-1, macrophage inflammatory protein (MIP)-2, intercellular adhesion molecule (ICAM)-1, nuclear factor (NF)-kappaB and early growth response (Egr)-1, nitric oxide (NO) and inducible nitric oxide synthase (iNOS) were detected. As a result, compared to the controls, Emodin had a notable effect on rat's living condition, pathological manifestation of hepatic tissue, total bilirubin, direct bilirubin, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (P<0.05), but had little effect on alkaline phosphatase (ALP), gamma-glutamyltransferase (GGT) and total bile acid. With Emodin intervention, levels of TNF-alpha, IL-6, MPO, MDA, CINC-1, MIP-2, ICAM-1 and translocation of NF-kappaB were remarkably decreased, and levels of NO and iNOS were markedly increased (P<0.05). Emodin had no effect on Egr-1. In conclusion, Emodin has a protective effect on hepatocytes and a restoring activity on cholestatic hepatitis by anti-inflammation. The effects are mainly due to antagonizing pro-inflammatory cytokines and mediators, inhibiting oxidative damage, improving hepatic microcirculation, reducing impairment signals, and controlling neutrophil infiltration.
机译:大黄素,1,3,8-三羟基-6-甲基蒽醌,是大黄(Rheum officinale Baill)根中的蒽醌衍生物,数千年来一直用于治疗消化系统疾病。这项研究旨在揭示大黄素通过抗炎途径治疗胆汁淤积性肝炎的机制。在给予α-萘基异硫氰酸酯后,将大鼠分为大黄素,熊去氧胆酸,地塞米松,模型对照组和空白对照组。给药后24小时,48小时和72小时的时间,肝功能,肝组织的病理变化,肿瘤坏死因子(TNF)-α,白介素(IL)-6,髓过氧化物酶(MPO),丙二醛(MDA),超氧化物歧化酶(SOD),细胞因子诱导的中性粒细胞趋化因子(CINC)-1,巨噬细胞炎性蛋白(MIP)-2,细胞间黏附分子(ICAM)-1,核因子(NF)-κB和早期生长反应(Egr)-1 ,一氧化氮(NO)和诱导型一氧化氮合酶(iNOS)被检测到。结果,与对照组相比,大黄素对大鼠的生存状况,肝组织的病理学表现,总胆红素,直接胆红素,丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)有显着影响(P <0.05),但对碱性磷酸酶(ALP),γ-谷氨酰转移酶(GGT)和总胆汁酸的影响很小。在大黄素干预下,TNF-α,IL-6,MPO,MDA,CINC-1,MIP-2,ICAM-1的水平和NF-κB的转位显着降低,NO和iNOS的水平显着升高(P <0.05)。大黄素对Egr-1没有影响。总之,大黄素通过抗炎作用对肝细胞具有保护作用,对胆汁淤积性肝炎具有恢复活性。这种作用主要是由于拮抗促炎性细胞因子和介质,抑制氧化损伤,改善肝微循环,减少损伤信号以及控制中性粒细胞浸润。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号